Connecticut 2017 Regular Session

Connecticut Senate Bill SB00435 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 General Assembly Proposed Bill No. 435
22 January Session, 2017 LCO No. 3113
33 *03113*
44 Referred to Committee on PUBLIC HEALTH
55 Introduced by:
66 SEN. SLOSSBERG, 14th Dist.
77
88 General Assembly
99
1010 Proposed Bill No. 435
1111
1212 January Session, 2017
1313
1414 LCO No. 3113
1515
1616 *03113*
1717
1818 Referred to Committee on PUBLIC HEALTH
1919
2020 Introduced by:
2121
2222 SEN. SLOSSBERG, 14th Dist.
2323
2424 AN ACT PROVIDING ACCESS TO PRESCRIPTION BRANDS THAT ARE MEDICALLY NECESSARY FOR PEOPLE DIAGNOSED WITH EPILEPSY.
2525
2626 Be it enacted by the Senate and House of Representatives in General Assembly convened:
2727
2828 That the general statutes be amended to provide access to prescription brands that are medically necessary for the treatment of persons diagnosed with epilepsy.
2929
3030 Statement of Purpose:
3131
3232 To provide access to prescription drug brands that are medically necessary for the treatment of persons diagnosed with epilepsy.